ERBB2 and breast cancer: In this regard, it was found that CUR in combination with 5FU exerted a synergistic cytotoxic effect in various breast cancer cell lines, including MCF-7, MDA-MB-231, SKBR3, and T47D, which are different in terms of receptor status and HER2 expression.